| SpectraBase Spectrum ID |
JEWnV2KsCDQ |
| Name |
3,4-Methylenedioxy-MAPA TMS II |
| Classification |
Designer drug precursor derivative |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
308.108000274 u |
| Formula |
C15H20O5Si |
| InChI |
InChI=1S/C15H20O5Si/c1-10(20-21(3,4)5)14(15(16)17-2)11-6-7-12-13(8-11)19-9-18-12/h6-8H,9H2,1-5H3/b14-10+ |
| InChIKey |
ZDEFLMVPJCQXCM-GXDHUFHOSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
308.405 g/mol |
| Nominal Mass |
308 u |
| Quality |
965 |
| Retention Index |
2199 |
| SMILES |
C1(\C(=C\(O[Si](C)(C)C)C)C(OC)=O)=CC2=C(C=C1)OCO2 |
| SPLASH |
splash10-0btc-3971000000-f6c703470b7f41e8ad16 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
MD-MAPA TMS II
methyl (2E)-2-(1,3-benzodioxol-5-yl)-3-((trimethylsilyl)oxy)but-2-enoate |
| Technique |
GC/MS |
| Wiley ID |
DD2024_032242 |
